Literature DB >> 19904614

Uptake of biodegradable gel-assisted LBL nanomatrix by Leishmania donovani-infected macrophages.

Girish K Gupta1, Shaswat Kansal, Pragya Misra, Anuradha Dube, Prabhat Ranjan Mishra.   

Abstract

The aim of this study was to develop novel gel-assisted layer-by-layer (LBL) nanomatrix with high payload of doxorubicin (DOX) and to assess its efficacy against Leishmania donovani. The biodegradable LBL nanomatrix was fabricated using LBL technique using polyions (protamine and sodium alginate) on decomposable core. The developed system was characterized in vitro in terms of layer-by-layer growth and payload efficiency. The efficacy of optimized formulations was evaluated against L. donovani strain in terms of inhibitory concentration (IC50). Uptake studies by infected macrophages were investigated both qualitatively and quantitatively using fluorescence microscopy and flow cytometry. The autogelling property subsequent to core removal inside the nanomatrix resulted in high payload efficiency of DOX (i.e., >70%). The reversal in charge followed the same trend with additional layers, and the magnitude of the charge remained constant up to five complete bilayers of polyions. The DOX can be effectively encapsulated, delivered, and subsequently taken up by L. donovani-infected macrophage cells. The matrix is completely internalized into macrophages showing improved efficacy (IC50 of formulation is almost <or=1.9-fold as compared to plain drug, P<0.05) against intracellular amastigotes. Having ample of opportunity to manipulate surface architecture, this system demonstrates unique platform as a low cost ideal substitute for visceral leishmaniasis to expensive lipid-based formulations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904614      PMCID: PMC2799600          DOI: 10.1208/s12249-009-9334-y

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  8 in total

1.  Antileishmanial activity of nano-amphotericin B deoxycholate.

Authors:  Krishna Das Manandhar; Thakur Prasad Yadav; Vijay Kumar Prajapati; Subodh Kumar; Madhukar Rai; Anuradha Dube; Onkar Nath Srivastava; Shyam Sundar
Journal:  J Antimicrob Chemother       Date:  2008-05-02       Impact factor: 5.790

2.  Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity.

Authors:  L Gille; H Nohl
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

3.  Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice.

Authors:  Georgy Hartmann; Vessela Vassileva; Micheline Piquette-Miller
Journal:  Drug Metab Dispos       Date:  2005-03-18       Impact factor: 3.922

4.  Microgel-based engineered nanostructures and their applicability with template-directed layer-by-layer polyelectrolyte assembly in protein encapsulation.

Authors:  Dinesh B Shenoy; Gleb B Sukhorukov
Journal:  Macromol Biosci       Date:  2005-05-23       Impact factor: 4.979

5.  Potential of doxorubicin as an antileishmanial agent.

Authors:  R Sett; N Basu; A K Ghosh; P K Das
Journal:  J Parasitol       Date:  1992-04       Impact factor: 1.276

6.  PEG-based hydrogels as an in vitro encapsulation platform for testing controlled beta-cell microenvironments.

Authors:  Laney M Weber; Jing He; Brenda Bradley; Kathryn Haskins; Kristi S Anseth
Journal:  Acta Biomater       Date:  2005-12-20       Impact factor: 8.947

7.  Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Authors:  J A Sánchez-Brunete; M A Dea; S Rama; F Bolás; J M Alunda; R Raposo; M T Méndez; S Torrado-Santiago; J J Torrado
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 8.  Advances in the treatment of leishmaniasis.

Authors:  Shyam Sundar; Madhukar Rai
Journal:  Curr Opin Infect Dis       Date:  2002-12       Impact factor: 4.915

  8 in total
  4 in total

1.  Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.

Authors:  Pramod K Gupta; Anil K Jaiswal; Shalini Asthana; Venkatesh Teja B; Prashant Shukla; Minakshi Shukla; Neeti Sagar; Anuradha Dube; Srikanta K Rath; Prabhat R Mishra
Journal:  Br J Pharmacol       Date:  2015-05-19       Impact factor: 8.739

2.  Investigational drugs for visceral leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Investig Drugs       Date:  2014-11-20       Impact factor: 6.206

3.  Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.

Authors:  Pramod K Gupta; Anil K Jaiswal; Shalini Asthana; Ashwni Verma; Vivek Kumar; Prashant Shukla; Pankaj Dwivedi; Anuradha Dube; Prabhat R Mishra
Journal:  Pharm Res       Date:  2014-11-26       Impact factor: 4.200

4.  Coating doxorubicin-loaded nanocapsules with alginate enhances therapeutic efficacy against Leishmania in hamsters by inducing Th1-type immune responses.

Authors:  S Kansal; R Tandon; A Verma; P Misra; A K Choudhary; R Verma; P R P Verma; A Dube; P R Mishra
Journal:  Br J Pharmacol       Date:  2014-07-25       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.